Skip to main content

Table 4 Effect of SQ-LNS containing different amounts and sources of zinc along with malaria and diarrhea treatment on prevalence of anemia, iron deficiency and iron deficiency anemia in children aged 9 – 18 months

From: Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial

 

LNS-Zn0

LNS-Zn5

LNS-Zn10

LNS-TabZn5

P-value among 4 intervention groupsb

IC

NIC

P-value between cohortsb

% Anemia (Hb <110 g/L)a

 At 9 months, N (%)

76 (95.0)

69 (94.5)

72 (94.7)

62 (91.2)

0.794

279 (93.9)

80 (91.9)

0.515

 At 18 months, N (%)

62 (77.5)

57 (78.1)

52 (68.4)

48 (70.6)

0.503

219 (73.7)

80 (91.9)

0.0007

% Low plasma ferritin (pF <12 μg/L)

 Low unadjusted pF at 9 months, N (%)

12 (14.3)

10 (13.3)

9 (11.4)

10 (13.7)

0.950

41 (13.2)

11 (11.8)

0.575

 Low adjusted pF at 9 months, N (%)

18 (21.4)

25 (33.3)

12 (15.2)

17 (23.3)

0.049

72 (23.1)

29 (31.2)

0.126

 Low unadjusted pF at 18 months, N (%)

4 (4.8)

2 (2.7)

6 (7.6)

6 (8.2)

0.476

18 (5.8)

19 (20.4)

<0.0001

 Low adjusted pF at 18 months, N (%)

9 (10.7)

6 (8.0)

16 (20.2)

11 (15.1)

0.109

42 (13.5)

30 (32.3)

0.0001

% Elevated soluble transferrin receptor (sTfR >8.3 mg/L)

 High unadjusted sTfR at 9 months, N (%)

77 (91.7)

73 (97.3)

75 (94.9)

70 (95.9)

0.355

295 (94.8)

84 (90.3)

0.100

 High adjusted sTfR at 9 months, N (%)

71 (84.5)

71 (94.7)

73 (92.4)

69 (94.5)

0.080

284 (91.3)

79 (84.9)

0.163

 High unadjusted sTfR at 18 months, N (%)

38 (45.2)

37 (49.3)

41 (51.9)

36 (49.3)

0.884

152 (48.9)

70 (75.3)

0.001

 High adjusted sTfR at 18 months, N (%)

31 (36.9)

30 (40.0)

35 (44.3)

31 (42.5)

0.725

127 (40.8)

66 (71.0)

<0.0001

% Low body iron stores (BIS <0 mg/kg)

 Low unadjusted BIS at 9 months, N (%)

31 (36.9)

37 (49.3)

33 (41.8)

29 (39.7)

0.260

130 (41.8)

38 (40.9)

0.782

 Low adjusted BIS at 9 months, N (%)

37 (44.0)b

50 (66.7)a

44 (55.7)ab

39 (53.4)ab

0.049

170 (54.7)

58 (62.4)

0.248

 Low unadjusted BIS at 18 months, N (%)

8 (9.5)

7 (9.3)

11 (13.9)

11 (15.1)

0.641

37 (11.9)

31 (33.3)

0.0001

 Low adjusted BIS at 18 months, N (%)

9 (10.7)

15 (20.0)

16 (20.3)

16 (21.9)

0.385

56 (18.0)

43 (46.2)

<0.0001

% Elevated capillary zinc protoporphyrin (ZPP >70 μmol/mol heme)

 High unadjusted ZPP at 9 months, N (%)

78 (96.3)

71 (97.3)

79 (100.0)

71 (97.3)

1.000

299 (97.7)

84 (91.3)

0.968

 High adjusted ZPP at 9 months, N (%)

78 (96.3)

71 (97.3)

79 (100.0)

71 (97.3)

1.000

299 (97.7)

84 (91.3)

0.968

 High unadjusted ZPP at 18 months, N (%)

80 (98.8)

71 (97.3)

78 (98.7)

72 (98.6)

0.844

301 (98.4)

92 (100.0)

0.982

 High adjusted ZPP at 18 months, N (%)

80 (98.8)

71 (97.3)

78 (98.7)

72 (98.6)

0.844

301 (98.4)

92 (100.0)

0.982

Iron deficiency anemia

% Low plasma ferritin and anemia

 Low unadjusted pF and anemia at 9 months, N (%)

11 (13.8)

10 (13.7)

8 (10.5)

10 (14.7)

0.933

39 (13.1)

10 (11.5)

0.632

 Low adjusted pF and anemia at 9 months, N (%)

15 (18.8)

24 (32.9)

11 (14.5)

17 (25.0)

0.064

67 (22.6)

27 (31.0)

0.130

 Low unadjusted pF and anemia at 18 months, N (%)

3 (3.8)

1 (1.4)

5 (6.6)

4 (5.9)

0.449

13 (4.4)

17 (19.5)

<0.0001

 Low adjusted pF and anemia at 18 months, N (%)

8 (10.0)

3 (4.1)

13 (17.1)

8 (11.8)

0.067

32 (10.8)

25 (28.7)

0.0002

% Elevated soluble transferrin receptor and anemia

 High unadjusted sTfR and anemia at 9 months, N (%)

71 (88.8)

68 (93.2)

68 (89.5)

60 (88.2)

0.656

267 (89.9)

75 (86.2)

0.667

 High adjusted sTfR and anemia at 9 months, N (%)

67 (83.8)

66 (90.4)

66 (86.8)

59 (86.8)

0.427

258 (86.9)

70 (80.5)

0.490

 High unadjusted sTfR and anemia at 18 months, N (%)

32 (40.0)

29 (39.7)

28 (36.8)

27 (39.7)

0.852

116 (39.1)

63 (72.4)

0.001

 High adjusted sTfR and anemia at 18 months, N (%)

26 (32.5)

24 (32.9)

22 (28.9)

24 (35.3)

0.882

96 (32.3)

59 (67.8)

<0.0001

  1. Hb hemoglobin concentration, pF plasma ferritin, sTfR soluble transferrin receptor, ZPP zinc protoporphyrin
  2. a n (%)
  3. bValues in a row with superscripts with different letters differ P < 0.05, using Proc GLIMMIX. Values are adjusted for the cluster effect of the village